Updated Jul 16, 2026
Frank Steven has filed 2 SEC Form 4 filings across 1 company in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-15 | BCRX | BIOCRYST PHARMACEUTICALS INC | A — Grant or award | 15.3K | $0.00 | |
| 2026-06-02 | BCRX | BIOCRYST PHARMACEUTICALS INC | A — Grant or award | 1.3K | $8.91 | $11K |
| 2026-03-16 | PGEN | PRECIGEN, INC. | M — Option exercise | 71.8K | — | |
| 2026-03-12 | PGEN | PRECIGEN, INC. | A — Grant or award | 14.2K | $3.51 | $50K |
| 2026-03-03 | BCRX | BIOCRYST PHARMACEUTICALS INC | A — Grant or award | 1.3K | $8.75 | $11K |
| 2025-08-29 | BCRX | BIOCRYST PHARMACEUTICALS INC | A — Grant or award | 1.4K | $8.31 | $11K |
Frank Steven is a corporate insider — currently tracked as Director of BIOCRYST PHARMACEUTICALS INC (BCRX). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Frank Steven profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.